114 related articles for article (PubMed ID: 29190947)
1. Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer.
Schultz MA; Diaz AM; Smite S; Lay AR; DeCant B; McKinney R; Mascarinas WE; Xia Y; Neumann C; Bentrem D; Dawson DW; Grippo PJ
Oncotarget; 2017 Nov; 8(54):92667-92681. PubMed ID: 29190947
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.
Sun YL; Cai JQ; Liu F; Bi XY; Zhou LP; Zhao XH
World J Gastroenterol; 2015 Oct; 21(38):10840-52. PubMed ID: 26478675
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.
Taniuchi K; Furihata M; Hanazaki K; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
Pancreas; 2015 Mar; 44(2):331-40. PubMed ID: 25426613
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
Fukuda A
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin-1 promotes cell proliferation and metastasis through enhancing Akt/mTOR in human osteosarcoma cells.
Cai AL; Zeng W; Cai WL; Liu JL; Zheng XW; Liu Y; Yang XC; Long Y; Li J
Oncotarget; 2018 Feb; 9(9):8290-8302. PubMed ID: 29492195
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
[TBL] [Abstract][Full Text] [Related]
7. Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Lee JC; Shin J; Baek KH
Biochem Biophys Res Commun; 2013 Oct; 440(1):50-5. PubMed ID: 24041692
[TBL] [Abstract][Full Text] [Related]
8. Identification of thioredoxin-1 as a biomarker of lung cancer and evaluation of its prognostic value based on bioinformatics analysis.
Liu X; Dong X; Hu Y; Fang Y
Front Oncol; 2023; 13():1080237. PubMed ID: 36776308
[TBL] [Abstract][Full Text] [Related]
9. Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas.
Maier HJ; Wagner M; Schips TG; Salem HH; Baumann B; Wirth T
Oncogene; 2013 May; 32(21):2690-5. PubMed ID: 22751123
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674
[TBL] [Abstract][Full Text] [Related]
12. Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1.
Aguilar-Melero P; Prieto-Álamo MJ; Jurado J; Holmgren A; Pueyo C
J Proteomics; 2013 Feb; 79():161-71. PubMed ID: 23277276
[TBL] [Abstract][Full Text] [Related]
13. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
14. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress.
Poschmann G; Grzendowski M; Stefanski A; Bruns E; Meyer HE; Stühler K
Biochim Biophys Acta; 2015 Jun; 1854(6):624-31. PubMed ID: 25484280
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis identifies protein disulfide isomerase and peroxiredoxin 1 as new players involved in embryonic interdigital cell death.
Shan SW; Tang MK; Cai DQ; Chui YL; Chow PH; Grotewold L; Lee KK
Dev Dyn; 2005 Jun; 233(2):266-81. PubMed ID: 15858817
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
17. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
18. Prdx1-encoded peroxiredoxin is important for vascular development in zebrafish.
Huang PC; Chiu CC; Chang HW; Wang YS; Syue HH; Song YC; Weng ZH; Tai MH; Wu CY
FEBS Lett; 2017 Mar; 591(6):889-902. PubMed ID: 28231391
[TBL] [Abstract][Full Text] [Related]
19. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
20. Silencing thioredoxin induces liver cancer cell senescence under hypoxia.
Zhang T; Liu H; Zhu C; Briggs K; Kang Y; Fleming JA; Curley SA
Hepatol Res; 2012 Jul; 42(7):706-13. PubMed ID: 22414001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
